The Docusate Sodium Capsules, cataloged under National Stock Number 6505-01-116-4955, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Consolidated Midland Corp. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 3 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-116-4955 |
| Primary Part Number | NDC00223-0855-30 |
| Item Name | Docusate Sodium Capsules |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Consolidated Midland Corp |
| Status | ACTIVE |
| Active Medicament Medicinal Strength | 250.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 30.000 |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00223-0855-30 PRIMARY | Consolidated Midland Corp (USA) |
| 13716 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00182-0182-17 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
NSN 6505-01-116-4955 is a Docusate Sodium Capsules, manufactured by Consolidated Midland Corp, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-116-4955 has 3 cross-referenced part numbers: NDC00223-0855-30 (Consolidated Midland Corp), 13716 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00182-0182-17 (Goldline Laboratories, Inc. Dba Goldline Laboratories).
There are 3 known substitutes for 6505-01-116-4955: 5330-00-291-6397, 3020-01-148-9548, 5950-01-157-8424. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00223-0855-30: Active Medicament Medicinal Strength: 250.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 30.000; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 4 total characteristics are documented in the Federal Logistics Information System.